Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Research Notes|April 6, 2017
Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetesDaya Ram Pokharel, Dipendra Khadka, Manoj Sigdel, et al.
Health Science Reports|July 7, 2023
Prevalence of exposure to needle stick and sharp-related injury and status of hepatitis B vaccination among healthcare workers: A cross-sectional studyK C Rupak, Dipendra Khadka, Sabal Ghimire, et al.
North American Journal of Medical Sciences|September 30, 2015
Estimation of 10-Year Risk of Coronary Heart Disease in Nepalese Patients with Type 2 Diabetes: Framingham Versus United Kingdom Prospective Diabetes StudyDaya Ram Pokharel, Dipendra Khadka, Manoj Sigdel, et al.
Journal of Inflammation Research|August 22, 2022
Augmentation of NAD<sup>+</sup> by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in MiceSeung Hoon Lee, Hyung-Jin Kim, Gi-Su Oh, et al.
International Journal of Molecular Sciences|November 13, 2021
Modulation of Cellular NAD<sup>+</sup> Attenuates Cancer-Associated Hypercoagulability and Thrombosis via the Inhibition of Tissue Factor and Formation of Neutrophil Extracellular TrapsWa Cao, Meng-Yu Zhu, Seung-Hoon Lee, et al.
Hearing Research|April 21, 2015
Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicityHyung-Jin Kim, Gi-Su Oh, AiHua Shen, et al.
Aging Cell|July 30, 2019
Augmentation of cellular NAD<sup>+</sup> by NQO1 enzymatic action improves age-related hearing impairmentHyung-Jin Kim, Wa Cao, Gi-Su Oh, et al.
Hearing Research|September 6, 2015
Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolismHyung-Jin Kim, Arpana Pandit, Gi-Su Oh, et al.
Biochemical and Biophysical Research Communications|October 27, 2015
Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD(+) metabolismArpana Pandit, Hyung-Jin Kim, Gi-Su Oh, et al.
Journal of Molecular and Cellular Cardiology|October 7, 2018
Augmentation of NAD<sup>+</sup> levels by enzymatic action of NAD(P)H quinone oxidoreductase 1 attenuates adriamycin-induced cardiac dysfunction in miceDipendra Khadka, Hyung-Jin Kim, Gi-Su Oh, et al.
Pageof 3